RCKT FY 2020 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RCKTRocket Pharmaceuticals, Inc.

$572M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$136M

Net Income

-$147M

EPS (Diluted)

$-2.52

Cash Flow

Operating Cash Flow

-$75M

Free Cash Flow

-$104M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$591M

Total Liabilities

$87M

Stockholders' Equity

$504M

Cash & Equivalents

$297M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	-$426,000	-168.8%
Operating Income	-$136M	-$76M	-78.6%
Net Income	-$147M	-$83M	-76.2%